Development of a Rapid and Fully Automated Factor VIII Inhibitor Assay, Insensitive to Emicizumab, and a Lowest Level of Quantification of 0.2 BU/mL.
Journal of Thrombosis and Haemostasis(2024)
Key words
acquired hemophilia,Bethesda assay,FVIII inhibitors,hemophilia,Nijmegen assay
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined